OpenVSafe by OpenVAERS
Search V-safe

FW2-39524-10113

2 vaccinations 4 coded responses 7 check-ins 4 free-text entries 1 call case
Sex
Male
Age at first dose
46-50
ZIP prefix
025 / MA
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-19
    Registered in v-safe
  2. 2021-03-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  4. 2021-03-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood pressure increased, Chest discomfort, Hyperhidrosis, Injection site pain, Pre-existing disease — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Last three days sweaty palms most of day, arm pain near injection site,, sensation of high blood pressure, tight chest, feels muscular though. I do have pre existing CHF w LBB, however after taking pulse and rhythm readings my what I'm feeling is not caused by my preexisting conditions directly..
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  6. 2021-03-26
    Survey response — day 7, dose 1
    MedDRA: Hypersensitivity — Feeling: Poor · Fatigue or tiredness · Be unable to work
    Free text: Hypertensive
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-02
    Survey response — day 14, dose 1
    MedDRA: Balance disorder, Dyspnoea, Fatigue, Hyperhidrosis, Tachycardia, Vision blurred — Feeling: Good · Be unable to do your normal daily activities
    Free text: Dyspnea tachycardia profuse palm sweating fatigue balance issues (like being on a ship), blurred vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-09
    Dose 2 — Pfizer-BioNTech
  9. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  10. 2021-07-12
    Survey response — 3 months, dose 2
    MedDRA: Balance disorder, Chest discomfort, Fatigue, Headache, Hypoaesthesia, Loss of consciousness, Vertigo — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Chest pressure headaches vertigo passed out once fatigue, feet feel numb or like sandbags, lose balance always to the right
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-07-12
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-07-23
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-03-19Pfizer-BioNTech
22021-04-09Pfizer-BioNTech

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-24

Systemic reaction (other): Last three days sweaty palms most of day, arm pain near injection site,, sensation of high blood pressure, tight chest, feels muscular though. I do have pre existing CHF w LBB, however after taking pulse and rhythm readings my what I'm feeling is not caused by my preexisting conditions directly..

Release 6 — day 7, dose 1

2021-03-26

Systemic reaction (other): Hypertensive

Release 6 — day 14, dose 1

2021-04-02

Symptoms: Dyspnea tachycardia profuse palm sweating fatigue balance issues (like being on a ship), blurred vision

Release 9 — 3 months, dose 2

2021-07-12

Symptoms: Chest pressure headaches vertigo passed out once fatigue, feet feel numb or like sandbags, lose balance always to the right

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBalance disorder ✓ ✓ ✓
SDChest discomfort ✓ ✓ ✓
SDDizziness ○ ○ ○
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHyperhidrosis ✓ ✓ ✓
SDHypoaesthesia ✓ ✓ ✓
SDLoss of consciousness ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓
SDVertigo ✓ ✓ ✓
SDVision blurred ✓ ✓ ✓
SROBlood pressure increased ✓ ✓ ✓
SROChest discomfort ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROHypersensitivity ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release